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Light exposure of aqueous suspensions of prednisolone and dexamethasone causes their partial phototransforma-
tion. The photoproducts, isolated by chromatographic techniques, have been identiﬁed by spectroscopic means.
Prednisolone, dexamethasone and their photoproducts have been tested to evaluate their acute and chronic toxic eﬀects
on some freshwater chain organisms. The rotifer Brachionus calyciﬂorus and the crustaceans Thamnocephalus platyurus
and Daphnia magna were chosen to perform acute toxicity tests, while the alga Pseudokircheneriella subcapitata (for-
merly known as Selenastrum capricornutum) and the crustacean Ceriodaphnia dubia to perform chronic tests. The
photochemical derivatives are more toxic than the parent compounds. Generally low acute toxicity was found. Chronic
exposure to this class of pharmaceuticals caused inhibition of growth population on the freshwater crustacean C. dubia
while the alga P. subcapitata seems to be less aﬀected by the presence of these drugs.
 2003 Elsevier Ltd. All rights reserved.
Keywords: Prednisolone; Dexamethasone; Phototransformation; Acute and chronic toxicity1. Introduction
The issue of drugs in the aquatic environment has
raised increasing concern in recent years since these
substances have the potential to impact both human and
wildlife populations (Halling-Sorensen et al., 1998;
Daughton and Ternes, 1999).
Many drugs, which are persistent, have been found in
surface waters (Zuccato et al., 2000; Jones et al., 2002)
and some toxicological studies on aquatic life organisms
have revealed their harmfulness (Halling-Sorensen et al.,
1998; Daughton and Ternes, 1999). Generally these in-
vestigations have reported only acute toxicity data, but
it would be more relevant to perform also life cycle*Corresponding author. Fax: +39-081674393.
E-mail address: dellagre@unina.it (M. DellaGreca).
0045-6535/$ - see front matter  2003 Elsevier Ltd. All rights reserv
doi:10.1016/j.chemosphere.2003.09.008tests on organisms representing diﬀerent trophic layers
to identify the hazard of drugs in the aquatic envi-
ronment. Furthermore, a little work has been devoted
to the drugs that are not stable in the environment
and are subjected to transformations. In such cases
the analytical and toxicological assessments should
be addressed towards their transformation products
(Fig. 1).
In a recent study on prednisone (1) (DellaGreca
et al., 2003) we have shown that this drug undergoes
transformation by sunlight. After eight hours of expo-
sure to a solar simulator, 60% of prednisone was
transformed into seven photoproducts. The acute and
chronic toxic eﬀects of the parent compound and its
photoderivatives were evaluated on a battery of diﬀerent
freshwater species and the results showed that some
photoproducts were stable and more toxic than the
parent drug.ed.
Fig. 1. Structure of compounds 1–12.
630 M. DellaGreca et al. / Chemosphere 54 (2004) 629–637Prednisone is a corticosteroid, a drug similar to the
natural hormone cortisone used in several forms to treat
many diﬀerent conditions.
The wide range of pharmacological properties put
corticosteroids among the most used drugs in the world,
and in continuing our study on the fate and the toxicity
of these substances we have now examined prednisolone
(2) and dexamethasone (3). Both drugs are used for their
potent anti-inﬂammatory eﬀects and the ﬁrst is a me-
tabolite of prednisone in man (Maayan et al., 1988).
Furthermore, both drugs are reported to be sensitive to
light (Takacs et al., 1991).The aim of the present study was to assess the be-
haviour of these drugs under sunlight irradiation and
evaluate their acute toxic eﬀects on primary consumers
of the aquatic chain (the rotifer Brachionus calyciﬂorus,
the crustaceans Daphnia magna and Thamnocephalus
platyurus) as well as subtle eﬀects through chronic tests
on a producer (the alga Pseudokircheneriella subcapitata)
and a consumer (the crustacean Ceriodaphnia dubia).
Toxicity tests were performed on the parent pharma-
ceuticals and on their photoderivatives. Results dem-
onstrate that phototransformation products can elicit
severe chronic eﬀects mainly on C. dubia.
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2.1. General procedures
Nuclear magnetic resonance (NMR) spectra were
recorded at 500 MHz for [1H] and 125 MHz for [13C] on
a Fourier Transform NMR Varian 500 Unity Inova
spectrometer and at 400 MHz for [1H] and 100 MHz for
[13C] on a Bruker AC 400 spectrometer. The carbons
multiplicity was evidenced by DEPT experiments. The
proton couplings were evidenced by 1H–1H COSY ex-
periments. The heteronuclear chemical shift correla-
tions were determined by HMQC and HMBC pulse
sequences. 1H–1H proximities through space within a
molecule were determined by NOESY.
Electronic impact mass spectra (EI-MS) were ob-
tained with a HP 6890 spectrometer equipped with a MS
5973 N detector. Infrared spectra (IR) were determined
on a Fourier Transform Infrared Perkin-Elmer 1740
spectrometer in CHCl3 solutions (0.025 M). Ultraviolet
spectra (UV) were recorded in ethanol (104 M) on a
Perkin-Elmer LAMBDA 7 spectrophotometer. High-
performace liquid chromatography (HPLC) was per-
formed on a Varian Vista 5500 apparatus equipped with
a refractometric detector and Lichrosorb RP-8 columns.
Irradiation experiments were performed with a 150 W
solar simulator Oriel equipped with a Xenon lamp
(spectral output 200–2400 nm).2.2. Phototransformation of prednisolone (2)
A suspension of prednisolone (2) (100 mg) in water
(500 ml) was irradiated by the solar simulator for 4 h
under slow magnetic stirring. The reaction mixture was
extracted with ethyl acetate and the residue was sub-
jected to silica gel ﬂash chromatography. Elution with
CHCl3–acetone (19:1) gave a mixture of products 7–10
(5 mg), while elution with CHCl3–CH3OH (19:1) gave
unreacted prednisolone (2) (55 mg), pure 4 (14 mg) and
crude 5 and 6. TLC chromatography on silica gel
(CHCl3–CH3OH 19:1) gave pure 5 (9 mg). Reverse-
phase C-18 HPLC chromatography (H2O–CH3OH–
CH3CN 6:2:2) gave pure 6 (11 mg).2.3. Synthesis of 1,4-androstadien-11b-olo-3,17-dione (7)
To a solution of prednisolone (2) (200 mg) in ethyl
acetate (10 ml) MnO2 (4 g) was added. After 1 h at
room temperature the reaction mixture was ﬁltered on
celite eluting with ethyl acetate and methanol. Chro-
matography on silica gel (CHCl3–acetone 19:1) of the
ﬁltrate gave 1,4-androstadien-11b-olo-3,17-dione (7)
(170 mg).2.4. Phototransformation of 1,4-androstadien-11b-olo-
3,17-dione (7)
A suspension of 1,4-androstadien-11b-olo-3,17-dione
(7) (180 mg) in water (1000 ml) was irradiated by the
solar simulator for 4 h under magnetic stirring. The re-
action mixture was separated by silica gel ﬂash chro-
matography (CHCl3–acetone 19:1) into its components
7 (140 mg), 8 (15 mg), 9 (8 mg) and 10 (20 mg).
2.5. Phototransformation of dexamethasone (3)
Dexamethasone (3) (100 mg) suspended in water (500
ml) was irradiated by a solar simulator for 8 h. The
organic material was extracted with AcOEt (2 · 150 ml)
and chromatographed by ﬂash chromatography on sil-
ica gel. Elution with CHCl3–acetone (7:3) gave three
fractions A–C. Fraction A (85 mg) consisted of unre-
acted 3. TLC chromatography on silica gel of fraction B
(CHCl3–CH3OH 93:7) gave 12 (4 mg) while TLC
chromatography (organic phase of the mixture hexane–
CH2Cl2–CH3OH–H2O 10:40:17:8) of fraction C gave 11
(4 mg).
2.6. Chemicals
Prednisolone (2) and dexamethasone (3) were pur-
chased from Sigma–Aldrich.
2.7. Acute toxicity testing
Acute toxicity was determined on primary consumers
typical of the aquatic chain: the rotifer B. calyciﬂorus
and the crustaceans D. magna and T. platyurus. All the
organisms were provided in cryptobioticstages by Mi-
croBioTests Inc., Nazareth, Belgium. The test on D.
magna was performed according to the ISO (Interna-
tional Organization for Standardization) 6341, the test
on B. calyciﬂorus following the ASTM (American Soci-
ety for Testing and Materials, 1991) E1440-91, while the
test on T. platyurus following the manufacturer proce-
dure.
Prednisolone, dexamethasone and their photoderiv-
atives were dissolved in dimethylsulphoxide (DMSO)
and further diluted in double-deionized water to make
the ﬁnal stock solutions. The DMSO concentration in
the exposure solutions, including controls, was 0.01%
(v/v) that is a non-eﬀect dose as estimated in preliminary
tests. All bioassays were conducted under static condi-
tions, with no renewal of the test solution, measuring
dissolved oxygen and pH in each sample both at the
start and at the end of testing. At the same time as
toxicity testing, reference tests were performed with
potassium dichromate (Aldrich) for all the organisms.
Juveniles (age, 0–2 h) of the rotifer B. calyciﬂorus
were hatched from cysts after 16–18 h of incubation
632 M. DellaGreca et al. / Chemosphere 54 (2004) 629–637under a light source of 3000–4000 lux at 25 C in syn-
thetic reconstituted medium (moderately hard medium
EPA-600/4-85-013) and then exposed to the test sample.
Hardness was 80–100 mg/l CaCO3 and the dissolved
oxygen content was at least 90% saturation at the be-
ginning of the test. Tests were run in 36-well plates, ﬁve
rotifers per well (0.3 ml of test solution, slightly diﬀerent
from the ASTM procedure), six replicates for each of the
ﬁve concentrations. Test duration was 24 h, temperature
25 C, in the dark. The test parameter considered was
mortality and the concentration found to kill 50% roti-
fers in 24 h was indicated as LC50.
The bioassay on the anostracan crustacean T.
platyurus was conducted using second- and third-instar
fairy shrimp larvae hatched from cysts after 20–22 h of
incubation at 25 C in synthetic reconstituted freshwater
(the same moderately hard EPA medium as rotifers)
under continuous illumination (light source 3000–4000
lux). Tests were performed in 24-well plates, ten crus-
taceans per well (1.0 ml of test solution), three replicates
for each of the ﬁve concentrations. Test duration was 24
h, temperature 25 C, in the dark. The test parameter
considered was mortality and the concentration found
to kill 50% crustaceans in 24 h was indicated as LC50.
The test on D. magna Straus was performed using
juveniles (age< 24 h), hatched from ephippia after 3–4
days of incubation at 20 C under continuous illumi-
nation (light source 10 000 lux). The synthetic reconsti-
tuted freshwater, aerated before use, was the ISO hard
medium (hardness 250 mg/l expressed as CaCO3). Tests
were performed with neonates < 24 h, ﬁve daphnids per
vessel (10 ml of test solution), four replicates for each of
the ﬁve concentrations. Daphnids were exposed to the
samples at temperature of 20 C in the dark. After 24 h
the number of immobile daphnids was recorded to de-
termine the sample concentration able to achieve 50%
immobilization and it was indicated as EC50. D. magna
was considered to be immobilized if it was not able to
swim after gentle agitation of the liquid in 15 s of ob-
servation even if it can still move its antennae (ISO,
1996).
2.8. Chronic toxicity testing
The eﬀects of the investigated drugs and their deriv-
atives on the population growth inhibition were assessed
using standard methods for chronic toxicity tests on the
alga P. subcapitata (already known as Selenastrum cap-
ricornutum) and the crustacean C. dubia.
The algal growth inhibition test was run in 72 h ac-
cording to the ISO procedure 8692 (ISO, 1987). The P.
subcapitata inoculum (1 · 104 cells/ml) was taken from
an exponentially growing pre-culture (strain CCAP 278/
4) and poured in 25 ml of test solution in ﬁve concen-
trations and three replicates. Flasks were placed in a
growth chamber at 25 C under continuous illumination(8000 lux). The cell density was measured at 0 time and
every 24 h for 3 days by an electronic particle dual
threshold counter (Coulter Counter Z2, 100 lm capil-
lary, Instrumentation Laboratory, Miami, FL, USA).
The test on C. dubia was run in 7 days and performed
on young daphnids (<24 h old at the start of the expo-
sure), obtained by acyclical parthenogenesis of individ-
ual adult females for at least three generations. The ﬁrst
females were born from the hatching of ephippia pro-
vided by MicroBioTests. Organisms were exposed indi-
vidually to seven concentrations in beakers with 20 ml of
synthetic reconstituted aerated hard ISO medium (total
hardness 250 mg/l as CaCO3) and the desired concen-
tration of single compounds. Each treatment consisted
of ten replicates per concentration incubated at 25 C
with a 16:8-h light: dark cycle (500 lux). Daphnids were
fed daily with 100 ll of a suspension of the alga P.
subcapitata (4 · 108 cells/ml), food ﬁsh (5 g/l) and yeast
(5 g/l). Also test solutions were renewed daily as well as
survival and oﬀspring production assessed. From com-
parison between the number of oﬀspring born from live
or dead mothers at the end of the test in the sample
batch and the control it was possible to calculate the
concentration which gave rise to 50% population growth
inhibition (ISO, 2001).
2.9. Data analysis
Raw data for all bioassays, except algal test, were
analyzed using the ToxcalcTM (1996). For acute toxicity
tests, the LC50s and EC50s were calculated by concen-
tration/response regression using probit or trimmed
Spearman–Karber method, as appropriate (Peltier and
Weber, 1985). For the test with C. dubia, the value of the
concentration that gave 50% population growth inhibi-
tion was calculated using Maximum Likelihood-Logit
method. Raw test data from algae were analyzed by a
Microsoft Excel 5.0 program (Phoenix, AZ, USA) tai-
lored for this test. Algal growth inhibition (%) was cal-
culated by integrating the mean values of cell density
from t0 to t72 h. Inhibition (%) values were tabulated
against log-transformed data of concentrations to eval-
uate the test concentration corresponding to 50% algal
growth inhibition.3. Results and discussion
3.1. Phototransformation studies
Irradiation of an aqueous suspension of prednisolone
(2) by a solar simulator for 4 h gave a complex mixture,
which was resolved in its components by chromatogra-
phies. Along with unreacted prednisolone, the photo-
products 4–10, identiﬁed by their spectroscopic features,
were isolated.
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hydroxyderivative 4 by comparison of its spectral data
(Appendix A) with those of the analogous photoproduct
of prednisone (1) (DellaGreca et al., 2003). According to
the structure the HRMS showed a molecular peak at
m=z 378.2063 for the molecular formula C21H30O6.
Furthermore in the HMBC experiment the H-1 proton
was correlated to the C-3, C-5 and C-10 carbons and the
H-19 protons gave heterocorrelations with the C-5 and
C-10 carbons.
Structure 5 was attributed to the second photo-
product. It had molecular formula C21H28O5 according
to the molecular peak at m=z 360.1915 in its HRMS
spectrum. The 1H and 13C NMR resonance (Appendix
A) were assigned by combination of COSY, TOCSY,
DEPT, HMQC and HMBC experiments. The HMBC
spectrum showed the correlations of the C-10 oleﬁnic
carbon with the H-2, H-4, H-6, H-7 and H-19 protons,
as well as that of the C-3 carbonyl carbon with the H-22
and H-4 protons and that of the C-5 carbon with the H-
4, H-6, H-7, H-9 and H-19 protons. The correlation in a
TOCSY experiment between the H-4 and H-11 protons
supported the presence of an ethereal bridge between the
C-4 and C-11 carbons. The stereostructure of 5 derived
from a ROESY experiment. The correlations with the
H-18 methyl and the H-21 methylene protons allowed
the assignment of the b-orientation to the H-12 protons
at d 2.20 and, consequently the a-one to the H-12 proton
at d 2.53. These nOe’s pointed out a chair conformation
of the C ring and the small couplings of the H-11 proton
with the H-12 protons agreed with its a equatorial ori-
entation. The correlation of the H-4 proton with the H-
11 revealed its a-orientation and, consequently the b-one
of the ethereal bridge. Finally the a axial orientation of
H-19 methyl was supported by the nOe interaction of its
protons with the H-4a proton.
The third compound was identiﬁed as 6. It had mo-
lecular formula C21H30O6 according to the molecular
peak at m=z 360.1922 in the HR EIMS spectrum. The
1H-NMR and 13C-NMR data (Appendix A), compared
with those of the corresponding photoderivative of
prednisone, justiﬁed the structural assignment. As al-
ready veriﬁed on prednisone (1) (DellaGreca et al., 2003)
the light caused also the degradation of the side chain at
C-17. In fact the fourth photoproduct was identiﬁed as
11b-hydroxy-androsta-1,4-diene-3,17-dione (7) by com-
parison with an authentic sample obtained by MnO2
oxidation of prednisolone. Structures 8–10 were attrib-
uted to the remaining compounds owing to the strong
analogies of their physical features with those of 4–6.
The photochemical behavior of dexamethasone (3)
only partly matched that of prednisone (1) and predn-
isolone (2). In fact, the irradiation with the solar simu-
lator for 8 h of its aqueous suspension converted
dexamethasone (3) only in 15% amount and the pho-
toderivatives 11 and 12 were isolated, without trace ofthe products obtained by degradation of the side chain
at C-17. The data (Appendix A) of compounds 11 and
12 compared with those of 5 and 6, justiﬁed the structure
assignments.
The formation of the 5a-hydroxyderivative 4 may be
easily justiﬁed by a hydration reaction on the less hin-
dered a-face of the D4 double bond (Scheme 1). The
formation of the prednisolone photoderivatives 5 and 6
ﬁnd explanation in the generally accepted mechanism
for photoisomerization of cross-conjugated steroidal
dienones (Williams et al., 1979). The light induced for-
mation of cyclopropyl derivative 13, protonation and
subsequent attack of H2O on the a-face generates 6.
Isomerization of 13 into the lumiprednisolone 14 fol-
lowed by the attack of the hydroxyl group at C-11 on the
C-4 position aﬀords the ether 5. The phototransforma-
tion of 1 into 2 by side chain degradation, and the same
steps reported in Scheme 1 for prednisolone, justify the
formation of 8–10.
3.2. Toxicity studies
Acute toxicity data are reported in Table 1 for
prednisolone and its photoproducts and in Table 2 for
dexamethasone and the respective derivatives. Despite
of the high concentrations tested, prednisolone 2 did not
demonstrate a measurable value of LC50/EC50 except
for rotifers. All the other compounds showed values by
the order of units or dozen of mg/l except compound 9
slightly more toxic for the all organisms tested. Dexa-
methasone 3 and its derivatives 11 and 12 demonstrated
such an activity as prednisolone photoproducts but also
for these compounds the concentrations ranged from
10.88 to 60.11 mg/l. These order of concentrations
should not be a problem because drug quantities found
in the surface waters are usually below parts per billion
(Aherne and Briggs, 1989; Raloﬀ, 1998; Ternes and
Wilken, 1999).
The long-term eﬀects are shown in Tables 3 and 4.
The detected drugs demonstrated a diﬀerent toxic po-
tential depending on the organism tested. Daphnids
were found to be signiﬁcantly more sensitive than algae.
This result was particularly evident for the parental
drugs where a median eﬀective concentration of 0.23 mg/
l was found for prednisolone on C. dubia against no
eﬀect at 160 mg/l for P. subcapitata. Also dexametha-
sone, while inhibited C. dubia 50% population growth at
0.05 mg/l, no eﬀect showed at 100 mg/l on the algal
growth. In this study algae showed median eﬀective
concentrations of the same order of magnitude than
LC50 and EC50 found for acute toxicity tests. Com-
pound 9 evidenced acute values for the all biota tested
less than the chronic ones found for the algae.
Both the photoderivatives of prednisolone and
dexamethasone showed eﬀects on C. dubia that lead to
long term action but, except compound 8 that was one
Scheme 1. Mechanism of phototransformation of prednisolone 1.
Table 1
Acute median eﬀective concentrations in mg/l (95% conﬁdence limits in brackets) of prednisolone and its phototransformation
products
Compounds D. magna (EC50) T. platyurus (LC50) B. calyciﬂorus (LC50)
2 NEa 85 23% mortalb 140 22.29 (20.82–24.56)
4 5.09 (3.98–6.54) 26.53 (18.44–38.13) 15.39 (12.58–18.84)
5 3.80 (2.70–5.33) 22.92 (17.16–30.61) 24.54 (20.82–28.92)
6 17.88 (14.06–22.74) 40.77 (25.18–66.01) 35.46 (30.46–41.29)
7 9.05 (7.20–11.37) 10.79 (8.52–13.67) 9.19 (5.52–15.23)
8 5.74 (4.81–6.85) 10.57 (8.21–13.59) 10.36 (7.47–14.37)
9 1.79 (1.38–2.32) 0.71 (0.5–1.0) 1.43 (1.14–1.81)
10 11.89 (9.78–14.46) 10.0 (7.58–13.18) 9.96 (8.46–11.74)
aNE¼no eﬀect at.
bMortal¼mortality at.
Table 2
Acute median eﬀective concentrations in mg/l (95% conﬁdence limits in brackets) of dexamethasone and its phototransformation
products
Compounds D. magna (EC50) T. platyurus (LC50) B. calyciﬂorus (LC50)
3 48.30 (39.91–58.45) 60.11 (44.21–81.73) 48.22 (41.37–56.20)
11 10.88 (7.28–16.26) 20.9 (16.49–26.50) 13.20 (11.43–15.23)
12 17.82 (13.84–22.94) 30.52 (25.54–46.66) 44.66 (38.91–51.25)
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pounds 9 and 10 ten times, other signiﬁcant diﬀerenceswere not expressed. These chronic data diﬀer from those
of prednisone and its photoderivatives (DellaGreca
Table 3
Chronic median eﬀective concentrations in ppm (95% conﬁdence limits in brackets) of prednisolone and its phototransformation
products
Compounds C. dubia (7 days test) P. subcapitata (3 days test)
2 0.23 (0.16–0.28) NEa 160
4 0.22 (0.16–0.30) 27.46 (25.07–30.07)
5 0.12 (0.07–0.19) 30.42 (28.10–32.94)
6 0.22 (0.14–0.35) 24.65 (21.32–28.50)
7 0.51 (0.31–1.16) 14.14 (8.68–23.03)
8 0.007 (0.00026–0.026) 19.84 (17.98–21.88)
9 0.04 (0.018–0.06) 23.78 (11.75–48.13)
10 0.025 (0.014–0.038) 25.62 (20.32–28.90)
aNE¼ no eﬀect at.
Table 4
Chronic median eﬀective concentrations in ppm (95% conﬁdence limits in brackets) of dexametasone and its phototransformation
products
Compounds C. dubia (7 days test) P. subcapitata (3 days test)
3 0.05 (0.042–0.076) NEa 100
11 0.13 (0.11–0.15) 12.15 (8.96–16.49)
12 0.06 (0.04–0.08) 40.75 (36.35–45.69)
aNE¼ no eﬀect at.
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tions harmful for the aquatic environment for predni-
sone compared with its photoproducts.4. Conclusions
These laboratory studies evidence that prednisolone
(2) and dexamethasone (3) are transformed by sunlight
and enable to identify and to quantify the phototrans-
formation products. Results from this study demon-
strate that the chronic exposure to this class of
pharmaceuticals causes inhibition of growth population
on the freshwater crustacean C. dubia while the alga P.
subcapitata seems to be less aﬀected by the presence of
these drugs. The low values of acute toxicity found for
B. calyciﬂorus, D. magna and T. platyurus do not de-
termine an acute environmental risk. Photoderivatives
showed higher toxicity than parental compounds but the
order of magnitude of eﬀective concentrations was lower
than drug quantities generally found in surface waters.
In conclusion the results give a strong indication on
the importance of investigating the environmental fate
of drugs and identifying their transformation products
to assess their impact.Acknowledgements
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Compound 4 had ½aD +18.0 (c 0.5): EIMS m=z 378
[M]þ, 360 [M-H2O]þ, 319 [M-C2H3O2]þ; IR (CHCl3):
mmax 3677, 3409, 1710 cm1; UV kmax 231 nm; 1H-NMR:
d (C5D5N) 7.78 (1H, d, J ¼ 5, 6 Hz, H-1), 6.69 (1H, d,
J ¼ 5, 6 Hz, H-2), 5.26 (1H, d, J ¼ 19:2 Hz, H-21), 4.82
(1H, d, J ¼ 19:2 Hz, H-21), 4.72 (1H, brs, H-11), 3.20
(1H, d, J ¼ 19:2 Hz, H-4), 3.12 (1H, m, H-16), 2.05 (1H,
d, J ¼ 19:2 Hz, H-4), 1.25 (3H, s, H-18), 1.20 (3H, s, H-
19); 13C-NMR: d (C5D5N) 168.2 (C-1), 134.2 (C-2),
209.1 (C-3), 46.4 (C-4), 74.7 (C-5), 34.3 (C-6), 28.2 (C-7),
31.8 (C-8), 50.8 (C-9), 54.5 (C-10), 69.2 (C-11), 39.5 (C-
12), 47.7 (C-13), 51.7 (C-14), 24.0 (C-15), 34.6 (C-16),
89.6 (C-17), 17.9 (C-18), 23.4 (C-19), 213.4 (C-20), 67.6
(C-21).
Compound 5 had ½aD )159.0 (c 0.7): EIMS m=z 360
[M]þ, 342 [M-H2O]þ, 301 [M-C2H3O2]þ; IR (CHCl3):
mmax 3685, 3505, 1727, 1710 cm1; UV kmax 256 nm; 1H-
NMR: d (C5D5N) 5.34 (1H, dt, J ¼ 2:1 and 7.2 Hz, H-
1), 5.27 (1H, d, J ¼ 19:2 Hz, H-21), 4.82 (1H, d,
J ¼ 19:2 Hz, H-21), 3.11 (1H, ddd, J ¼ 2:1, 4.1 and 15.2
Hz, H-2a), 3.02 (1H, ddd, J ¼ 3:1, 11.6 and 14.7 Hz, H-
16b), 2.62 (1H, dd, J ¼ 7:2 and 15.2 Hz, H-2b), 2.53
(1H, dd, J ¼ 4:5 and 14.5 Hz, H-12a), 2.20 (1H, dd,
J ¼ 1:7 and 14.5 Hz, H-12b). 13C-NMR: d (C5D5N)
116.6 (C-1), 38.4 (C-2), 204.3 (C-3), 86.6 (C-4), 54.0 (C-
5), 26.2 (C-6), 26.9 (C-7), 31.2 (C-8), 54.3 (C-9), 145.6
636 M. DellaGreca et al. / Chemosphere 54 (2004) 629–637(C-10), 77.9 (C-11), 32.8 (C-12), 48.2 (C-13), 49.1 (C-14),
22.9 (C-15), 34.2 (C-16), 89.3 (C-17), 17.5 (C-18), 25.0
(C-19), 213.0 (C-20), 67.5 (C-21).
Compound 6 had EIMS m=z 360 [M]þ, 1H-NMR: d
(CDCl3) 5.90 (1H, d, J ¼ 1:3 Hz, H-4), 4.69 (1H, brs, H-
11), 4.64 (1H, d, J ¼ 19:2 Hz, H-21), 4.27 (1H, d,
J ¼ 19:2 Hz, H-21), 0.90 (3H, s, H-19), 1.15 (3H, s, H-
18). 13C-NMR: d (CD3OD) 58.3 (C-1), 37.3 (C-2), 212.8
(C-3), 131.5 (C-4), 188.3 (C-5), 32.1 (C-6), 30.9 (C-7),
40.4 (C-8), 62.7 (C-9), 76.8 (C-10), 70.3 (C-11), 40.3 (C-
12), 40.3 (C-13), 53.7 (C-14), 26.0 (C-15), 34.7 (C-16),
90.8 (C-17), 18.7 (C-18), 20.4 (C-19), 213.8 (C-20), 68.1
(C-21).
Compound 7 had 1H-NMR: d (CD3OD) 7.45 (1H, d,
J ¼ 5:9 Hz, H-1), 6.24 (1H, d, J ¼ 5:9 Hz, H-2), 6.01
(1H, brs, H-4), 4.39 (1H, brs, H-11), 1.18 (3H, s, H-18),
1.52 (3H, s, H-19). 13C-NMR: d (CD3OD) 161.0 (C-1),
128.0 (C-2), 189.5 (C-3), 123.0 (C-4), 174.9 (C-5), 35.0
(C-6), 33.1 (C-7), 32.5 (C-8), 57.5 (C-9), 46.8 (C-10), 71.1
(C-11), 42.0 (C-12), 46.8 (C-13), 53.2 (C-14), 23.7 (C-15),
37.0 (C-16), 214.4 (C-17), 17.5 (C-18), 22.5 (C-19).
Compound 8 had 1H-NMR: d (CDCl3) 7.70 (1H, d,
J ¼ 5:9 Hz, H-1), 6.18 (1H, d, J ¼ 5:9 Hz, H-2), 4.46
(1H, brs, H-11), 2.84 (1H, d, J ¼ 19:5 Hz, H-4), 1.92
(1H, d, J ¼ 19:5 Hz, H-4), 1.15 (3H, s, H-19), 1.09 (3H,
s, H-18). 13C-NMR: d (CDCl3) 167.1 (C-1), 134.8 (C-2),
209.9 (C-3), 45.9 (C-4), 74.8 (C-5), 33.9 (C-6), 26.8 (C-7),
31.0 (C-8), 51.8 (C-9), 54.3 (C-10), 69.6 (C-11), 40.2 (C-
12), 47.0 (C-13), 51.5 (C-14), 23.2 (C-15), 35.5 (C-16),
219.3 (C-17), 16.1 (C-18), 21.7 (C-19).
Compound 9 had 1H-NMR: d (CDCl3) 5.44 (1H, dt,
J ¼ 2:1 and 7.2 Hz, H-1), 4.45 (1H, brs, H-11), 4.18 (1H,
s, H-4), 1.08 (3H, s, H-18), 1.40 (3H, s, H-19). 13C-
NMR: d (CDCl3) 116.4 (C-1), 37.9 (C-2), 204.1 (C-3),
86.4 (C-4), 53.9 (C-5), 25.7 (C-6), 25.2 (C-7), 30.5 (C-8),
54.7 (C-9), 144.8 (C-10), 76.7 (C-11), 33.0 (C-12), 47.4
(C-13), 48.9 (C-14), 25.2 (C-15), 35.3 (C-16), 219.7 (C-
17), 15.6 (C-18), 21.0 (C-19).
Compound 10 had 1H-NMR: d (CD3OD) 5.94 (1H,
s, H-4), 4.68 (1H, m, H-11), 1.17 (6H, s, H-18, H-19).
13C-NMR: d (CD3OD) 58.2 (C-1), 36.7 (C-2), 212.6 (C-
3), 131.7 (C-4), 187.9 (C-5), 32.0 (C-6), 29.4 (C-7), 40.4
(C-8), 63.4 (C-9), 76.8 (C-10), 69.7 (C-11), 41.1 (C-12),
41.1 (C-13), 53.9 (C-14), 23.9 (C-15), 36.7 (C-16), 215.0
(C-17), 17.1 (C-18), 20.5 (C-19).
Compound 11 had 1H-NMR: d (CD3OD) 5.45 (1H,
dt, J ¼ 2:0 and 7.0 Hz, H-1), 4.63 (1H, d, J ¼ 19:5 Hz,
H-21), 4.27 (1H, d, J ¼ 19:5 Hz, H-21), 4.21 (1H, s, H-
4), 4.19 (1H, m, H-11), 3.18 (1H, m, H-6), 3.02 (1H, m,
H-16b), 3.00 (1H, m, H-2), 2.75 (1H, dd, J ¼ 7:0 and
15.6 Hz, H-2), 2.38 (1H, brs, H-6), 2.25 (3H, m, H-7, H-
12 and H-14), 1.80 (1H, m, H-12), 1.65 (1H, m, H-15),
1.53 (1H, m, H-7), 1.37 (3H, s, H-19), 1.17 (1H, m, H-
15), 0.92 (4H; 1H, m, H-8; 3H, d, J ¼ 5:6 Hz, H-22),
0.90 (3H, s, H-18). 13C-NMR: d (CD3 OD) 116.8 (C-1),
38.0 (C-2), 203.5 (C-3), 85.7 (C-4), 53.0 (C-5), 25.1 (C-6),30.0 (C-7), 36.2 (C-8), 99.7 (C-9), 143.8 (C-10), 98.1 (C-
11), 31.2 (C-12), 49.6 (C-13), 42.5 (C-14), 21.2 (C-15),
34.3 (C-16), 90.1 (C-17), 17.0 (C-18), 20.5 (C-19), 212.1
(C-20), 67.8 (C-21), 14.9 (C-22).
Compound 12 had 1H-NMR: d (CD3OD) 5.98 (1H,
s, H-4), 4.62 (1H, d, J ¼ 19:1 Hz, H-21), 4.52 (1H, m, H-
11), 4.29 (1H, d, J ¼ 19:1 Hz, H-21), 3.09 (1H, m, H-
16b), 3.01 (1H, m, H-2), 2.65 (1H, m, H-2), 2.51 (2H, m,
H-6 e H-60), 2.51 (1H, m, H-7), 2.38 (1H, m, H-12), 2.21
(1H, m, H-14), 1.77 (2H, m, H-1, H-7), 1.68 (1H, m, H-
15), 1.46 (1H, m, H-12), 1.3 (1H, m, H-15), 1.25 (1H, m,
H-8), 1.22 (3H, s, H-19), 1.00 (3H, s, H-18), 0.89 (3H, d,
J ¼ 17:2 Hz, H-22). 13C-NMR: d (CD3OD) 50.3 (C-1),
37.2 (C-2), 212.5 (C-3), 131.8 (C-4), 187.9 (C-5), 32.7 (C-
6), 35.2 (C-7), 41.6 (C-8), 103.8 (C-9), 79.1 (C-10), 72.4
(C-11), 40.4 (C-12), 49.9 (C-13), 45.8 (C-14), 25.3 (C-15),
37.2 (C-16), 92.6 (C-17), 18.3 (C-18), 20.6 (C-19), 213.2
(C-20), 68.5 (C-21), 15.9 (C-22).References
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